Actualités

PhD projects 2020: antibodies subjects funded in Tours and Montpellier

Please find below the list of PhD projects funded from 2020 on, in Tours and Montpellier, in the antibody field. This list is susceptible to changes as co-fundings are obtained by the teams. For more information on the project or the recruitment procedure, please refer to the link provided for each subject.

Tours 

Unravelling the oxytocine-vasopressin system to improve social interaction deficits in mouse models of autism.

See more

Scientific Responsible name  : Dr. Lucie Pellissier (UMR PRC)

Funder(s) : ERC – MAbImprove

 

Selective modulation of FSH receptor-induced signaling pathways in vivo, consequences on ovarian and testicular functions.

See more

Scientific Responsible name : Dr. Eric Reiter (UMR PRC)

Funder(s) : INRA – MAbImprove

 

Inhaled anticancer Ab – improving their efficacy by boosting mucosal immune responses?

See more

Scientific Responsible name(s) : Dr. Nathalie Heuzé-Vourc’h (U1100 CEPR)

Funder(s) : Région CVL – MAbImprove

 

Study of the relationships between body composition and pharmacokinetics of therapeutic monoclonal antibodies in the treatment of metastatic colorectal cancer.

See more 

Scientific Responsible name(s) : Pr. Thierry Lecomte  – Dr David Ternant (EA 7501 GICC)

Funder(s) :Région CVL – MAbImprove

 

Analyse multi-échelle de production de biomédicaments par spectroscopie Raman

See more

Scientific Responsible name : Pr. Igor Chourpa (EA6295 NMNS)

Funder(s) : Fondation Philippe Maupas – MAbImprove

 

Thromboses associées aux thrombopénies induites par l’héparine: Nouveau mécanisme physiopathologique et perspective thérapeutique innovante.

See more

Scientific Responsible name : Dr. Jérôme Rollin (EA 7501 GICC)

Funder(s) : Région CVL – MAbImprove

 

Development of original armed antibodies for the breast cancer treatment »

See more

Scientific Responsible name(s) : Dr. Nicolas Joubert – Dr. Caroline Denevault (EA 7501 GICC)

Funder(s) : Projet région CVL – MAbImprove

 

Montpellier

Functional validation of a new type of therapeutic bi-specific antibody for applications in digestive cancers.

Selection done through CBS2 Doctoral School procedure

See More

Scientific Responsible name : Pr. Marie-Alix Poul (IRCM)

Funder(s) : Université de Montpellier – MAbImprove

 

Improving Natural Killer (NK)-based immunotherapy: Combination of monoclonal antibodies and chimeric antigen receptors (CAR NK).

Selection done through CBS2 Doctoral School procedure

See more

Scientific Responsible name : Dr Martin Villalba (IRMB)

Funder(s) : Université de Montpellier – MAbImprove